Roche now operates over 3,500 Nvidia Blackwell GPUs for AI-driven drug discovery, making it the pharma industry's largest ...

Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing ...

Strengthening collaboration to drive innovation across AI, biomedical research, and translational medicine PUNE, ...

In a highly competitive space, AI platforms must now prove themselves through proprietary data, focused pipelines and clinical readouts in competitive diseases. Promises of faster, cheaper drug ...

Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

Lancaster County man wanted on drug charges, resisting arrest turns himself in ...

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

Monday, March 16th at 1:30 PM PT, Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of ...

Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI - ...

Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans. The first-in-class clinical candidate, MK7602, is being developed by WEHI ...

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established constraints. Generative AI turns that on its head. It is an expansive force, ...